Timestrip® has introduced new time indicators to support the storage and handling of coronavirus vaccine supplies. These smart single use indicators provide an irreversible alert if the vaccine is stored in refrigerated conditions (2-8°C) for too long after thawing from deep freeze storage.
In an early case example, now that the Pfizer / Biontech vaccine has been approved for UK use, attention has turned to the logistics of supplying it to huge numbers of people. Timestrip indicators can travel with the vaccine supply and withstand the coldest storage temperatures e.g. down to -70°C, yet react when the vaccine consignment is thawed.
From the Timestrip vaccine range, the VRM30 indicator shows the time that vaccines have been held in the chilled 2-8°C range, and has markers for 1, 5 days up to 30 days, making it a suitable solution for the management of many vaccines including from Pfizer, Moderna / J&J and AstraZeneca. VRM30 is designed to compensate automatically for changes in temperature, responding more quickly in warmer conditions.
When the vaccine has been removed from the fridge into room temperature ready to be administered, a VOR12 indicator can be deployed to alert logistics and healthcare professionals that an 8°C threshold has been breached.
It will show the duration for which the vaccine has been Out of Refrigerator, as the indicator window gradually fills. A completely full window indicates that the maximum allowed storage period has been reached, and the vaccine may be compromised.
The eTimestrip range of electronic indicators comprises single use devices that generate a report via a mobile app, and provide detailed information on time and temperature to responsible healthcare staff. This report can be sent for centralised storage, eliminating the need to return the device itself for data analysis.
Conventionally, data loggers can be used in these applications, but the scale of the current challenge means that Timestrip’s small, robust indicators are a lower cost, practical solution, while supporting compliance with regulations.
We continue to innovate at a rapid pace to provide cost effective monitoring solutions, considering the efforts of the WHO, FDA and government bodies in their respective countries. Our main objective is supporting healthcare teams as they provide safe care to nations worldwide.Nora Murphy, Commercial Director